Evolving Therapy of Mantle Cell Lymphoma: Is There Still a Role for Upfront Transplant?
This information was originally presented on September 20, 2014, at the NCCN 9th Annual Congress: Hematologic Malignancies™ held in New York, New York.
This activity is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
Following this activity, participants should be able to:
- Assess the available clinical evidence supporting the use of consolidation therapy for patients with MCL
Issa F. Khouri, MD
The University of Texas MD Anderson Cancer Center
- 0.50 Participation
- 0.37 Nurse
- 0.50 Pharmacist
- 0.50 Physician